SARS-CoV-2 surrogate virus neutralization test based on antibody-mediated blockage of ACE2-spike protein binding
US11054429B1 · kind B1 · utility
4Cited by
1References
26Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Apr 1, 2021 |
| Grant date | Jul 6, 2021 |
| Priority date | — |
| Expiry date | Apr 1, 2041 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/12
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
A kit, composition and method for detection of antibodies to severe acute respiratory syndrome related coronavirus (SARSr-CoV), and for diagnosis of SARSr-CoV infection.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.